GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IDEXX Laboratories Inc (BSP:I1DX34) » Definitions » Cyclically Adjusted FCF per Share

IDEXX Laboratories (BSP:I1DX34) Cyclically Adjusted FCF per Share : R$5.17 (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is IDEXX Laboratories Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

IDEXX Laboratories's adjusted free cash flow per share for the three months ended in Mar. 2024 was R$1.997. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is R$5.17 for the trailing ten years ended in Mar. 2024.

During the past 12 months, IDEXX Laboratories's average Cyclically Adjusted FCF Growth Rate was 18.20% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 20.50% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 20.00% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 18.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of IDEXX Laboratories was 100.00% per year. The lowest was 11.90% per year. And the median was 20.50% per year.

As of today (2024-05-13), IDEXX Laboratories's current stock price is R$485.25. IDEXX Laboratories's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was R$5.17. IDEXX Laboratories's Cyclically Adjusted Price-to-FCF of today is 93.86.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of IDEXX Laboratories was 212.80. The lowest was 51.53. And the median was 101.93.


IDEXX Laboratories Cyclically Adjusted FCF per Share Historical Data

The historical data trend for IDEXX Laboratories's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IDEXX Laboratories Cyclically Adjusted FCF per Share Chart

IDEXX Laboratories Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 2.95 4.06 4.30 4.83

IDEXX Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.40 4.12 4.82 4.83 5.17

Competitive Comparison of IDEXX Laboratories's Cyclically Adjusted FCF per Share

For the Diagnostics & Research subindustry, IDEXX Laboratories's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IDEXX Laboratories's Cyclically Adjusted Price-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IDEXX Laboratories's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where IDEXX Laboratories's Cyclically Adjusted Price-to-FCF falls into.



IDEXX Laboratories Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, IDEXX Laboratories's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.997/129.4194*129.4194
=1.997

Current CPI (Mar. 2024) = 129.4194.

IDEXX Laboratories Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.292 100.560 0.376
201409 0.353 100.428 0.455
201412 0.051 99.070 0.067
201503 -0.248 99.621 -0.322
201506 0.372 100.684 0.478
201509 0.473 100.392 0.610
201512 0.540 99.792 0.700
201603 0.041 100.470 0.053
201606 0.716 101.688 0.911
201609 0.630 101.861 0.800
201612 0.636 101.863 0.808
201703 0.053 102.862 0.067
201706 0.699 103.349 0.875
201709 0.664 104.136 0.825
201712 0.733 104.011 0.912
201803 0.082 105.290 0.101
201806 0.776 106.317 0.945
201809 0.734 106.507 0.892
201812 0.847 105.998 1.034
201903 -0.034 107.251 -0.041
201906 0.909 108.070 1.089
201909 0.892 108.329 1.066
201912 1.030 108.420 1.229
202003 -0.246 108.902 -0.292
202006 2.205 108.767 2.624
202009 2.163 109.815 2.549
202012 2.422 109.897 2.852
202103 1.352 111.754 1.566
202106 2.453 114.631 2.769
202109 1.735 115.734 1.940
202112 2.339 117.630 2.573
202203 0.848 121.301 0.905
202206 0.425 125.017 0.440
202209 1.887 125.227 1.950
202212 1.554 125.222 1.606
202303 1.792 127.348 1.821
202306 1.998 128.729 2.009
202309 2.803 129.860 2.794
202312 2.537 129.419 2.537
202403 1.997 129.419 1.997

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


IDEXX Laboratories  (BSP:I1DX34) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

IDEXX Laboratories's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=485.25/5.17
=93.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of IDEXX Laboratories was 212.80. The lowest was 51.53. And the median was 101.93.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


IDEXX Laboratories Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of IDEXX Laboratories's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


IDEXX Laboratories (BSP:I1DX34) Business Description

Traded in Other Exchanges
Address
One IDEXX Drive, Westbrook, ME, USA, 04092
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 40% of its revenue from outside the United States.

IDEXX Laboratories (BSP:I1DX34) Headlines

No Headlines